Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Killer
Most Correlated Studies
- Va14 invariant natural killer T (Va14i NKT) cells harboring Th-POK (Zbtb7b) hd mutation
- Thymic invariant natural killer T cells (CD24- CD44+/- NK1.1-) with Id3 knockout
- Natural killer and natural killer T cells from Eomes reporter mice
- Invariant NKT cells from mice treated with alpha-galactosylceraminde 4wk and 1hr prior to analysis
- Mucosal invariant T cells stimulated with M. bovis and sorted as CD69+ CD26++ or CD69- CD26+/- cells
Most Relevant Literature
- Natural Killer Cells Dampen the Pathogenic Features of Recall Responses to Influenza Infection.
- Exploring the NK cell platform for cancer immunotherapy.
- 51Cr-release to monitor NK cell cytotoxicity.
- Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogen…
- Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.
Most Relevant Clinical Trials
- Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
- High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer
- High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma
- Anlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma
- Natural Killer (NK) Cell Transplantation for AML
